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See related article on page 215.doi:10.1016/j.jtcvs.2004.08.049In this issue of the Journal, Fasol and colleagues1 from Vienna describe theirtechnique for ablating atrial fibrillation in association with mitral valvesurgery by creating a triangular pattern of lesions endocardially in the leftatrium using irrigated unipolar radiofrequency. The triangular lesion patternis described in the text as encompassing the orifices of the 4 pulmonaryveins, with one corner of the triangle extending down to the mitral valve
annulus. However, in Figure 1 the triangle does not include the orifices of the right
pulmonary veins. In addition, in the legend for Figure 1, the authors state that the
triangle also encompasses the closed orifice of the unresected left atrial appendage,
although the figure itself clearly shows the closed appendage orifice to be outside the
confines of the triangle. Thus, it is unclear where the triangle is located from reading
the text and then observing Figure 1. Nevertheless, assuming that the triangle
encompasses all 4 pulmonary vein orifices, regardless of whether it includes the
closed orifice of the left atrial appendage, this lesion pattern is clearly simpler than
that of the classic maze procedure, as the authors correctly state. However, several
questions are left unanswered by the authors that affect the potential significance of
their study.
The 10 patients in this study are described as having had “chronic atrial fibril-
lation.” Other than noting that the atrial fibrillation had been “. . . preexisting for
longer than 6 months,” the authors do not clarify whether the term “chronic” refers
to the duration of the arrhythmia or to the fact that it was continuously present in
these patients. If “chronic” refers to the duration of the arrhythmia, and the patients
were not in continuous atrial fibrillation, they were, by definition, having recurrent
bouts of paroxysmal (intermittent) atrial fibrillation. In that case the authors had up
to a 90% chance of curing the atrial fibrillation by means of pulmonary vein
isolation alone, assuming that all of their lesions were transmural, because the
individual episodes of atrial fibrillation are dependent on an induction trigger that is
located within one or more of the pulmonary veins in as many as 90% of such
patients.2 In that case the 80% cure rate in this study would be about what is
expected. If, on the other hand, the authors are using the term “chronic” in the
traditional sense when applied to atrial fibrillation (ie, that the patients were in atrial
fibrillation all of the time), then the 80% cure rate attained by the authors is better
than expected. Because this success rate in patients with continuous atrial fibrillation
cannot be attained with simple pulmonary vein isolation alone, it would confirm the
importance of extending the triangle from the pulmonary veins down to the mitral
annulus, a point that I3-5 have emphasized in the past.
Perhaps the greatest importance of this article from the Vienna group is that it
once again emphasizes the importance of describing the preoperative diagnosis
accurately to interpret the results properly. This is the basis of the majority of the
confusion that currently exists in the field of atrial fibrillation therapy. During the
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patients with atrial fibrillation. Roughly 60% of those pa-
tients had intermittent atrial fibrillation, and the other 40%
were in atrial fibrillation continuously for an average of 8
years. Approximately 400 (approximately 10%) of those
patients underwent the maze procedure, many of whom had
intraoperative computerized mapping in the late 1980s and
early 1990s in which more than 150 electrodes were placed
on and inside the atria. We learned that atrial fibrillation,
once it is established, exhibits exactly the same macroreen-
trant pattern of activity in the atria during episodes of
paroxysmal (intermittent) atrial fibrillation as it does during
established permanent (continuous or chronic) atrial fibril-
lation. Unfortunately, despite our extensive experience in
mapping human atrial fibrillation, we were never able to
capture the spontaneous onset of a single episode of atrial
fibrillation. As a result, although our mapping studies clar-
ified the electrophysiologic basis of atrial fibrillation once it
actually occurs, they revealed nothing about the spontane-
ous induction of atrial fibrillation.
Characterization of precisely how atrial fibrillation is
induced awaited the studies of Haissaguerre and associates2
in 1998, who reported that paroxysmal (intermittent) atrial
fibrillation is usually induced by triggers located in the
pulmonary veins (90%) and occasionally by triggers located
outside the region of the pulmonary veins (10%). Although
others have reported slightly different numbers, all have
documented that each individual episode of paroxysmal
(intermittent) atrial fibrillation is dependent on a trigger or
triggers for induction and that most of the time those trig-
gers are located in the pulmonary veins. Once this informa-
tion became available, it was immediately clear that up to
90% of patients with paroxysmal (intermittent) atrial fibril-
lation could be cured by simple isolation of the pulmonary
veins, which, through isolation of the triggers responsible
for the arrhythmia, had the effect of stopping the arrhyth-
mia. That knowledge spurred the rapid development of new
tools and energy sources by the medical device industry to
allow interventional cardiologists and cardiac surgeons to
treat large numbers of patients with atrial fibrillation with a
technique that was less complex than the maze procedure.
Unfortunately, the study of Haissaguerre and associates2
was erroneously interpreted by many to mean that all atrial
fibrillation could be treated satisfactorily by simple pulmo-
nary vein isolation alone, including permanent (continuous)
atrial fibrillation, which is found in 40% of all patients with
the arrhythmia. That erroneous interpretation led many car-
diologists and surgeons to make the subsequent mistake of
using pulmonary vein isolation alone to treat continuous
atrial fibrillation, apparently not recognizing the simple fact
that atrial fibrillation that has been ongoing without inter-
ruption for many months or years does not need a trigger for
its induction but only a driver to sustain it. The subsequent
2 The Journal of Thoracic and Cardiovascular Surgery ● Januardismal early results of treating permanent (continuous)
atrial fibrillation with pulmonary vein isolation alone doc-
umented the irrationality of this approach.6
Several interesting things then happened. Some authors
began reporting success rates in the 60% to 80% range with
pulmonary vein isolation alone for all patients with atrial
fibrillation.7 At first glance, this seemed like a new and
significant advance that was inconsistent with the estab-
lished and generally accepted concepts of the induction2 and
maintenance3,8 of atrial fibrillation. However, on closer
inspection of these reports, it became apparent that their
ultimate overall success rates were directly proportional to
how many of their patients had paroxysmal (intermittent)
atrial fibrillation: the more patients with intermittent atrial
fibrillation, the higher the overall success rate for all patients
with atrial fibrillation. That was compatible with existing
theories because of the known efficacy of pulmonary vein
isolation in the treatment of intermittent atrial fibrillation. It
also became apparent, however, that many of those reports
classified long-standing intermittent atrial fibrillation as
chronic atrial fibrillation, thereby leading to the misconcep-
tion that continuous atrial fibrillation was being cured by
means of pulmonary vein isolation alone (a potential prob-
lem with the Vienna study in this issue of the Journal, as
mentioned above).
As a result of the reporting of interventional-surgical
results for both intermittent and continuous atrial fibrillation
as if they were one entity and of the semantic problem
caused by a lack of a proper classification system for atrial
fibrillation, it is virtually impossible to determine the true
success rates for interventional-surgical therapy. Two recent
developments have now increased the confusion by an order
of magnitude. First, several cardiologists decided that the
triggers in the pulmonary veins were responsible not only
for inducing individual episodes of intermittent atrial fibril-
lation but also for sustaining continuous atrial fibrillation, in
which case they were referred to as drivers.9 This notion
was seemingly augmented by the identification of what was
termed “pulmonary vein tachycardia,” or a consistent rapid
firing of foci (drivers) within the pulmonary veins in many
patients with continuous atrial fibrillation.10 In this scenario
the maintenance of sustained (continuous) atrial fibrillation
was attributed to continuous stimulation of the atria by this
tachycardia emanating from the pulmonary veins. Second,
some cardiologists have now reported that they can cure
more than 80% of continuous atrial fibrillation with simple
pulmonary vein isolation alone.11 On the basis of our con-
cept of the mechanisms involved in continuous atrial fibril-
lation that is simply not possible, although it would be if the
pulmonary vein tachycardia hypothesis was correct. Thus,
the crux of the controversy regarding the proper treatment
of continuous atrial fibrillation is the identification of ex-
actly what the drivers are that keep the atrial fibrillation
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contemporary concept to which most interventional cardi-
ologists subscribe is that the drivers are inside the pulmo-
nary veins, and therefore pulmonary vein isolation alone is
a rational treatment for continuous atrial fibrillation. Our
concept is that the drivers are actually the established mac-
roreentrant circuits in the atria that are capable of sustaining
themselves because of the well-documented phenomenon
described by Allessie12 called “electrical remodeling” of the
atria. In our concept the macroreentrant circuits in the atria
would have to be abolished to cure continuous atrial fibril-
lation, and simple pulmonary vein isolation alone has little
or nothing to do with its cure.
The first problem with the pulmonary vein tachycardia
concept is that the tachycardia is not constant. That being
the case, during the interludes when this pulmonary vein
tachycardia is not present, what drives the atrial fibrillation,
and why does the atrial fibrillation not stop at that point? No
answers to these questions have been provided. The second
problem is that if this hypothesis were correct, then the
success rate for pulmonary vein isolation alone should be
the same in patients with continuous atrial fibrillation as in
patients with intermittent atrial fibrillation. In reality, the
success rates, when precise and complete surgical lesions
are used to encompass the pulmonary veins, are wildly
different, being in the range of 90% for intermittent atrial
fibrillation and 15% to 25% for continuous atrial fibrilla-
tion.2,6 This simple observation alone is enough to refute the
concept that continuous atrial fibrillation is maintained by
drivers located in the pulmonary veins. But it does lend
intrigue to the question of how a few cardiology centers can
report success rates of more than 80% using pulmonary vein
isolation alone to treat continuous atrial fibrillation.
It is important to remember that there is such a thing as
surgical precision. When we surgeons report our results for
pulmonary vein isolation alone, regardless of the energy
source used, we are reporting the effects of placing a precise
line of ablation around the pulmonary vein orifices. No such
precision exists when cardiologists encircle the pulmonary
veins with an endocardial catheter. After the advent of
catheter ablation as a treatment for atrial fibrillation, I per-
formed maze procedures on approximately 35 patients in
whom prior catheter ablation procedures had failed, thereby
providing direct observation of the inside of the left atrium
after the attempted catheter ablations. The typical findings at
the time of the operation in these patients was diffuse
generalized scarring of the majority of the endocardium of
the left atrium as a result of the previous catheter ablation
attempts. I have never once seen a linear lesion of any type
in any patient who has undergone a previous catheter abla-
tion for atrial fibrillation. Moreover, I have yet to find a
single surgical colleague who has ever seen a linear lesion
inside the left atrium in any patient who has undergone a
The Journal of Thoracatheter ablation attempt at treating atrial fibrillation. This is
true whether the patient had undergone an attempt at pul-
monary vein isolation alone with a catheter or the addition
of other supposedly linear lesions that mimicked some or all
of the maze procedure. This observation has profound im-
plications in terms of what interventional cardiologists are
really doing to the inside of the left atrium in patients with
atrial fibrillation. Their patients are not receiving a simple
pulmonary vein isolation procedure as one would com-
monly envision that operation, but rather virtually the entire
inside of the patient’s left atrium is being obliterated, or at
least it was in the 35 left atria that I observed. This is an
entirely different interventional procedure in which so much
of the left atrium is destroyed that it is incapable of fibril-
lating; that is, the atrial macroreentrant circuits have all been
ablated because the atrial myocardium that harbored them
has been obliterated. The successful ablation of atrial fibril-
lation in these patients is understandable because dead atria
do not fibrillate. Unfortunately, the patients who are under-
going this procedure by cardiologists are almost certainly
unaware of the level of destruction that is being created
inside their left atria and that the lesions there bear no
resemblance whatsoever to a simple line of scar around the
pulmonary veins. Ideally, the interventional cardiologists
performing these procedures are unaware of this fact as
well. Regardless, this is the only way that 90% of continu-
ous atrial fibrillation can be cured by what is billed as
pulmonary vein isolation alone.
There are some simple steps that would correct this type
of confusion and suboptimal clinical care, and they would
also clarify the optimal method for treating patients with
different types of atrial fibrillation. The first is to agree on
the proper terminology, or classification, that would provide
an accurate and meaningful diagnosis preoperatively. We
have previously pointed out that although the new American
Heart Association/American College of Cardiology classi-
fication of atrial fibrillation13 is undoubtedly very helpful to
physicians who treat atrial fibrillation with drug or pacing
therapy, it is actually detrimental to the accuracy and un-
derstanding of treatment outcomes when used by physi-
cians, surgeons, or both who treat atrial fibrillation with the
creation of anatomic mechanical lines of conduction block
(catheter ablation or surgical intervention).8 The most im-
portant information for interventional cardiologists and sur-
geons is whether the patient has atrial fibrillation intermit-
tently or continuously because that dictates the pattern of
lines required for optimal results. The second issue on
which we need to agree is that the triggers for intermittent
atrial fibrillation are usually, although not always, within the
pulmonary veins and that the drivers that sustain continuous
atrial fibrillation are usually, although perhaps not always,
the macroreentrant circuits in the atria. These 2 steps would
allow the following simple, clear, and optimal interven-
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atrial fibrillation:
1. All patients with atrial fibrillation should have their
pulmonary veins isolated.
2. Patients with intermittent atrial fibrillation should have
additional lesions to preclude the development of atrial
macroreentry in the 10% of patients with triggers outside
the pulmonary veins unless the additional application of
such lesions cannot be technically created or represents an
additional hazard to the patient.
3. Patients with continuous atrial fibrillation should have
additional lesions to ablate atrial macroreentry.
If interventional cardiologists and surgeons would follow
these simple guidelines, their clinical results would im-
prove. Our combined efforts could then be focused on
determining what additional lesions are essential for success
and how best to apply those lesions. Unfortunately for the
patients, these additional lesions are difficult to apply
through a catheter, and therefore interventional cardiolo-
gists are left with the choices of (1) obtaining suboptimal
overall results, especially in the 40% of patients with con-
tinuous atrial fibrillation; (2) being more aggressive with
their ablation attempts and damaging large portions of the
left atrium; (3) redefining the basic mechanisms of atrial
fibrillation so that the additional lesions appear to be less
important than they actually are; or (4) sending their pa-
tients for surgical intervention. The most critical aspect in
this field at the present time is the controversy surrounding
the basic mechanism of how atrial fibrillation is induced and
sustained, and our ultimate understanding of this issue has
profound social, medical, and financial implications for the
future.
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